DSigDB Home
Search Gene
Collections
Browse Gene Sets
Download
Help

Gene Set: D4 : CTD - erlotinib


Collection D4 : CTD
Chemical Name erlotinib ( From PubChem : ERLOTINIB )
FDA NPC WHO Indian Australia China Traditional
Herbal
Clinical
Trail
ApprovedNotNotApprovedNotNotNotNot
Molecular
Weight
Hydrogen Bond
Donor Count
Hydrogen Bond
Acceptor Count
cLogP Lipinski Rule
393.436 g/mol 1 6 3.4781 True
Structure
InChI InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)
InChIKey AAKJLRGGTJKAMG-UHFFFAOYSA-N
Links

Gene (46 / 120)


⊖ Less

Source Type Unit Value Gene PMID Assay Other
CTDincreases(phosphorylation)ACACA
C400278
CTDaffects(response to substance)AREG
C400278
CTDdecreases(response to substance)ATG5
C400278
CTDincreases(expression)ATG5
C400278
CTDincreases(expression)ATG7
C400278
CTDdecreases(response to substance)AXL
C400278
CTDdecreases(activity)AXL
C400278
CTDincreases(response to substance)AXL
C400278
CTDincreases(expression)BCL2
C400278
CTDdecreases(reaction)BCL2
C400278
CTDincreases(response to substance)BCL2
C400278
CTDincreases(expression)BCL2L2
C400278
CTDdecreases(reaction)BCL2L2
C400278
CTDincreases(response to substance)BCL2L2
C400278
CTDdecreases(response to substance)BECN1
C400278
CTDdecreases(activity)BRCA1
C400278
CTDdecreases(phosphorylation)BRCA1
C400278
CTDdecreases(reaction)CCND1
C400278
CTDincreases(expression)CCND1
C400278
CTDdecreases(glycosylation)CDH1
C400278
CTDincreases(degradation)CDH1
C400278
CTDincreases(reaction)CDH1
C400278
CTDaffects(cotreatment)CHFR
C400278
CTDaffects(response to substance)CHFR
C400278
CTDdecreases(activity)CYP3A4
C400278
CTDincreases(expression)CYP3A4
C400278
CTDincreases(expression)DDIT3
C400278
CTDdecreases(reaction)EGF
C400278
CTDdecreases(response to substance)EGF
C400278
CTDincreases(reaction)EGF
C400278
CTDdecreases(reaction)EGF
C400278
CTDdecreases(response to substance)EGF
C400278
CTDaffects(binding)EGF
C400278
CTDincreases(reaction)EGF
C400278
CTDaffects(cotreatment)EGFR
C400278
CTDincreases(response to substance)EGFR
C400278
CTDaffects(response to substance)EGFR
C400278
CTDdecreases(response to substance)EGFR
C400278
CTDdecreases(reaction)EGFR
C400278
CTDincreases(activity)EGFR
C400278
CTDincreases(phosphorylation)EGFR
C400278
CTDdecreases(reaction)EGFR
C400278
CTDincreases(phosphorylation)EGFR
C400278
CTDdecreases(expression)EGFR
C400278
CTDdecreases(glycosylation)EGFR
C400278
CTDincreases(reaction)EGFR
C400278
CTDaffects(binding)EGFR
C400278
CTDincreases(reaction)EGFR
C400278
CTDdecreases(activity)EGFR
C400278
CTDdecreases(phosphorylation)EGFR
C400278
CTDdecreases(activity)EGFR
C400278
CTDdecreases(expression)EGFR
C400278
CTDdecreases(phosphorylation)EGFR
C400278
CTDdecreases(reaction)HBEGF
C400278
CTDdecreases(response to substance)HBEGF
C400278
CTDdecreases(phosphorylation)JAK2
C400278
CTDaffects(activity)KCNH2
C400278
CTDincreases(response to substance)KRAS
C400278
CTDdecreases(phosphorylation)MAPK1
C400278
CTDdecreases(phosphorylation)MAPK3
C400278
CTDaffects(cotreatment)MET
C400278
CTDdecreases(phosphorylation)MET
C400278
CTDdecreases(phosphorylation)MET
C400278
CTDdecreases(phosphorylation)MTOR
C400278
CTDincreases(expression)NOX4
C400278
CTDincreases(stability)NOX4
C400278
CTDdecreases(response to substance)NOX4
C400278
CTDaffects(binding)NR1I2
C400278
CTDincreases(activity)NR1I2
C400278
CTDincreases(expression)PML
C400278
CTDincreases(localization)PML
C400278
CTDdecreases(response to substance)PML
C400278
CTDdecreases(expression)PTPN9
C400278
CTDdecreases(response to substance)PTPN9
C400278
CTDdecreases(activity)RAD50
C400278
CTDdecreases(expression)RAD50
C400278
CTDdecreases(activity)RAD51
C400278
CTDdecreases(expression)RAD51
C400278
CTDdecreases(phosphorylation)RPS6
C400278
CTDdecreases(phosphorylation)RPS6KB1
C400278
CTDdecreases(phosphorylation)SRC
C400278
CTDincreases(phosphorylation)STAT3
C400278
CTDdecreases(reaction)STAT3
C400278
CTDincreases(response to substance)STAT3
C400278
CTDdecreases(reaction)TGFA
C400278
CTDdecreases(response to substance)TGFA
C400278
CTDdecreases(reaction)TGFB1
C400278
CTDdecreases(response to substance)TGFB1
C400278
CTDincreases(reaction)TGFB1
C400278
PubChem AhR Potency (uM)uM1.883AHR-GI(Protien) :
PubChem Potency-Replicate_1uM2.660AHR-GI(Protien) :
PubChem Potency-Replicate_1uM21.132AR-GI(Protien) :
PubChem PotencyuM20.666CLK4-GI(Protien) :
PubChem Potency-Replicate_1uM18.834CYP19A1-GI(Protien) :
PubChem NoneuMCYP19A1-GI(Protien) :
PubChem PotencyuM0.001EGFR-GI(Protien) :
PubChem PotencyuM0.001EGFR-GI(Protien) :
PubChem EGFR IC50uM0.001EGFR-GI(Protien) :
PubChem NoneuM0.350EGFR-GI(Protien) :
PubChem NoneuM0.470EGFR-GI(Protien) :
PubChem NoneuM0.480EGFR-GI(Protien) :
PubChem NoneuM0.520EGFR-GI(Protien) :
PubChem NoneuM0.520EGFR-GI(Protien) :
PubChem NoneuM0.670EGFR-GI(Protien) :
PubChem NoneuM0.850EGFR-GI(Protien) :
PubChem NoneuM0.970EGFR-GI(Protien) :
PubChem NoneuM1.200EGFR-GI(Protien) :
PubChem NoneuM1.600EGFR-GI(Protien) :
PubChem NoneuM3.100GAK-GI(Protien) :
PubChem irf1 Inhibition [HEL cells] (IC50)uM0.835JAK2-GI(Protien) :
PubChem Ratio Potency (uM)uM2.371NFE2L2-GI(Protien) :
PubChem Ratio Potency (uM)uM20.511NR3C1-GI(Protien) :
PubChem NoneuMSLK-GI(Protien) :
PubChem PotencyuM13.336TDP1-GI(Protien) :
PubChem PotencyuM0.972YES1GI(Protien) :
ChEMBLPotencynM20666.500CLK4
-Target : CHEMBL4203
ChEMBLInhibition-EGFR
-Target : CHEMBL203
ChEMBLPotencynM0.900EGFR
-Target : CHEMBL203
ChEMBLPotencynM0.800EGFR
-Target : CHEMBL203
ChEMBLActivityum0.835JAK2
-Target : CHEMBL2971
Download gene sets gmt, text, Detailed text
Contact us
Tan Lab , Mail Stop 8117
12801 East 17th Avenue
Division of Medical Oncology , Department of Medicine
University of Colorado School of Medicine
Aurora, CO 80045, USA

* Best viewed in the latest version of Chrome (42+), Safari (8+), IE (11+) or Firefox (35+).